Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

OBJECTIVE: To assess the feasibility and impact of highly active antiretroviral therapy (HAART) started in vertically HIV-1-infected infants less than 3 months of age. DESIGN: A multicentre, phase I/II, non-randomized, open-label study (PENTA 7). METHODS: Adverse events, plasma HIV-1 RNA, CD4 cell...

Full description

Bibliographic Details
Main Authors:	Aboulker, J, Babiker, A, Chaix, M, Compagnucci, A, Darbyshire, J, Debré, M, Faye, A, Giaquinto, C, Gibb, D, Harper, L, Saïdi, Y, Walker, A
Format:	Journal article
Language:	English
Published:	2004

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Similar Items